Report Detail

Pharma & Healthcare Global Oral Contraceptive Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2847371
  • |
  • 31 January, 2019
  • |
  • Global
  • |
  • 120 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.

Scope of the Report:
The worldwide market for Oral Contraceptive Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oral Contraceptive Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives

Market Segment by Applications, can be divided into
Hospital
Pharmacy
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Contraceptive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Contraceptive Drugs, with price, sales, revenue and global market share of Oral Contraceptive Drugs in 2017 and 2018.
Chapter 3, the Oral Contraceptive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Contraceptive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oral Contraceptive Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oral Contraceptive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Oral Contraceptive Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Long-acting Contraceptives
      • 1.2.2 Short-acting Contraceptives
      • 1.2.3 Emergency Contraceptives
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Pharmacy
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Bayer
      • 2.1.1 Business Overview
      • 2.1.2 Oral Contraceptive Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Bayer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Oral Contraceptive Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Teva Pharmaceutical
      • 2.3.1 Business Overview
      • 2.3.2 Oral Contraceptive Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Merck
      • 2.4.1 Business Overview
      • 2.4.2 Oral Contraceptive Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Merck Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Actavis
      • 2.5.1 Business Overview
      • 2.5.2 Oral Contraceptive Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Actavis Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Johnson & Johnson
      • 2.6.1 Business Overview
      • 2.6.2 Oral Contraceptive Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Gedeon Richter
      • 2.7.1 Business Overview
      • 2.7.2 Oral Contraceptive Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Novo Nordisk A/S
      • 2.8.1 Business Overview
      • 2.8.2 Oral Contraceptive Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 ZiZhu
      • 2.9.1 Business Overview
      • 2.9.2 Oral Contraceptive Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Baijingyu
      • 2.10.1 Business Overview
      • 2.10.2 Oral Contraceptive Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Huazhong
      • 2.11.1 Business Overview
      • 2.11.2 Oral Contraceptive Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oral Contraceptive Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oral Contraceptive Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oral Contraceptive Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oral Contraceptive Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oral Contraceptive Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oral Contraceptive Drugs Market Analysis by Regions

    • 4.1 Global Oral Contraceptive Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oral Contraceptive Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oral Contraceptive Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    5 North America Oral Contraceptive Drugs by Country

    • 5.1 North America Oral Contraceptive Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oral Contraceptive Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oral Contraceptive Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    6 Europe Oral Contraceptive Drugs by Country

    • 6.1 Europe Oral Contraceptive Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oral Contraceptive Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oral Contraceptive Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oral Contraceptive Drugs by Country

    • 7.1 Asia-Pacific Oral Contraceptive Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oral Contraceptive Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oral Contraceptive Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    8 South America Oral Contraceptive Drugs by Country

    • 8.1 South America Oral Contraceptive Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oral Contraceptive Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oral Contraceptive Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oral Contraceptive Drugs by Countries

    • 9.1 Middle East and Africa Oral Contraceptive Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oral Contraceptive Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oral Contraceptive Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oral Contraceptive Drugs Sales and Growth Rate (2014-2019)

    10 Global Oral Contraceptive Drugs Market Segment by Type

    • 10.1 Global Oral Contraceptive Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oral Contraceptive Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oral Contraceptive Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Long-acting Contraceptives Sales Growth and Price
      • 10.2.1 Global Long-acting Contraceptives Sales Growth (2014-2019)
      • 10.2.2 Global Long-acting Contraceptives Price (2014-2019)
    • 10.3 Short-acting Contraceptives Sales Growth and Price
      • 10.3.1 Global Short-acting Contraceptives Sales Growth (2014-2019)
      • 10.3.2 Global Short-acting Contraceptives Price (2014-2019)
    • 10.4 Emergency Contraceptives Sales Growth and Price
      • 10.4.1 Global Emergency Contraceptives Sales Growth (2014-2019)
      • 10.4.2 Global Emergency Contraceptives Price (2014-2019)

    11 Global Oral Contraceptive Drugs Market Segment by Application

    • 11.1 Global Oral Contraceptive Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Pharmacy Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Oral Contraceptive Drugs Market Forecast (2019-2024)

    • 12.1 Global Oral Contraceptive Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oral Contraceptive Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oral Contraceptive Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Oral Contraceptive Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oral Contraceptive Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Oral Contraceptive Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oral Contraceptive Drugs Market Forecast (2019-2024)
    • 12.3 Oral Contraceptive Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oral Contraceptive Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oral Contraceptive Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Oral Contraceptive Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oral Contraceptive Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oral Contraceptive Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Oral Contraceptive Drugs . Industry analysis & Market Report on Oral Contraceptive Drugs is a syndicated market report, published as Global Oral Contraceptive Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oral Contraceptive Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,773.56
      4,160.34
      5,547.12
      3,232.92
      4,849.38
      6,465.84
      532,196.40
      798,294.60
      1,064,392.80
      290,301.60
      435,452.40
      580,603.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report